These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23764835)

  • 1. Could yeast prion domains originate from polyQ/N tracts?
    Alexandrov AI; Ter-Avanesyan MD
    Prion; 2013; 7(3):209-14. PubMed ID: 23764835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence and evolution of yeast prion and prion-like proteins.
    An L; Fitzpatrick D; Harrison PM
    BMC Evol Biol; 2016 Jan; 16():24. PubMed ID: 26809710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion.
    DePace AH; Santoso A; Hillner P; Weissman JS
    Cell; 1998 Jun; 93(7):1241-52. PubMed ID: 9657156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appearance and propagation of polyglutamine-based amyloids in yeast: tyrosine residues enable polymer fragmentation.
    Alexandrov IM; Vishnevskaya AB; Ter-Avanesyan MD; Kushnirov VV
    J Biol Chem; 2008 May; 283(22):15185-92. PubMed ID: 18381282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.
    Meriin AB; Zhang X; He X; Newnam GP; Chernoff YO; Sherman MY
    J Cell Biol; 2002 Jun; 157(6):997-1004. PubMed ID: 12058016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast and Fungal Prions: Amyloid-Handling Systems, Amyloid Structure, and Prion Biology.
    Wickner RB; Edskes HK; Gorkovskiy A; Bezsonov EE; Stroobant EE
    Adv Genet; 2016; 93():191-236. PubMed ID: 26915272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide sequences converting polyglutamine into a prion in yeast.
    Odani W; Urata K; Okuda M; Okuma S; Koyama H; Pack CG; Fujiwara K; Nojima T; Kinjo M; Kawai-Noma S; Taguchi H
    FEBS J; 2015 Feb; 282(3):477-90. PubMed ID: 25406629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic polyglutamine tracts are potent inducers of spontaneous Sup35 and Rnq1 amyloidogenesis.
    Goehler H; Dröge A; Lurz R; Schnoegl S; Chernoff YO; Wanker EE
    PLoS One; 2010 Mar; 5(3):e9642. PubMed ID: 20224794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PrionW: a server to identify proteins containing glutamine/asparagine rich prion-like domains and their amyloid cores.
    Zambrano R; Conchillo-Sole O; Iglesias V; Illa R; Rousseau F; Schymkowitz J; Sabate R; Daura X; Ventura S
    Nucleic Acids Res; 2015 Jul; 43(W1):W331-7. PubMed ID: 25977297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prions of yeast as heritable amyloidoses.
    Wickner RB; Taylor KL; Edskes HK; Maddelein ML; Moriyama H; Roberts BT
    J Struct Biol; 2000 Jun; 130(2-3):310-22. PubMed ID: 10940235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prions of yeast are genes made of protein: amyloids and enzymes.
    Wickner RB; Edskes HK; Ross ED; Pierce MM; Shewmaker F; Baxa U; Brachmann A
    Cold Spring Harb Symp Quant Biol; 2004; 69():489-96. PubMed ID: 16117685
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.
    Derkatch IL; Uptain SM; Outeiro TF; Krishnan R; Lindquist SL; Liebman SW
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12934-9. PubMed ID: 15326312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the yeast prion world: Active prion conversion of non-glutamine/asparagine-rich Mod5 for cell survival.
    Suzuki G; Tanaka M
    Prion; 2013; 7(2):109-13. PubMed ID: 23117914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloids and yeast prion biology.
    Wickner RB; Edskes HK; Bateman DA; Kelly AC; Gorkovskiy A; Dayani Y; Zhou A
    Biochemistry; 2013 Mar; 52(9):1514-27. PubMed ID: 23379365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion model in yeast.
    Sapriel G
    Res Microbiol; 2001; 152(6):531-8. PubMed ID: 11501671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion diseases of yeast: amyloid structure and biology.
    Wickner RB; Edskes HK; Kryndushkin D; McGlinchey R; Bateman D; Kelly A
    Semin Cell Dev Biol; 2011 Jul; 22(5):469-75. PubMed ID: 21345375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid Properties of Asparagine and Glutamine in Prion-like Proteins.
    Zhang Y; Man VH; Roland C; Sagui C
    ACS Chem Neurosci; 2016 May; 7(5):576-87. PubMed ID: 26911543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Amyloid Polymorphism on Prion-Chaperone Interactions in Yeast.
    Killian AN; Miller SC; Hines JK
    Viruses; 2019 Apr; 11(4):. PubMed ID: 30995727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of polyglutamine toxicity by the yeast Sup35 prion domain in Drosophila.
    Li LB; Xu K; Bonini NM
    J Biol Chem; 2007 Dec; 282(52):37694-701. PubMed ID: 17956866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid Fragmentation and Disaggregation in Yeast and Animals.
    Kushnirov VV; Dergalev AA; Alexandrov AI
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.